Biospectrum Jobs

December 26th, 2025 | Friday

news4

WuXi Biologics Sets New ESG Benchmark with HERA 2025 Honour

WuXi Biologics has once again raised the bar for sustainability commitment and transparency. The company has been honored by the Hong Kong ESG Reporting Awards (HERA) 2025 for Outstanding ESG Disclosure, marking a new milestone in its dedication to openness and accountability. This recognition follows last year's ESG Report Benchmark Award from HERA, verifying the consistency of WuXi Biologics' progressive ESG journey. Beyond assuring compliance, ESG reporting is a strategic lever that helps gain trust and strengthen confidence among global clients, investors, regulators, and other stakeholders. Why does this matter? In today's business landscape, transparent ESG disclosure is a competitive advantage. WuXi Biologics' detailed reporting on its sustainability targets and progress – such as corporate governance, talent development and GHG emission reduction – reassures stakeholders that the company is driving meaningful change and shaping the future of Green CRDMO. Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, "Transparency is the cornerstone of trust. We firmly believe that openly sharing our ESG journey is essential, because only through collaboration can we help to create lasting value that contributes positively to society and the environment. Receiving the ESG Disclosure Award not only validates our efforts, but also inspires us to continue raising the bar as we lead the industry toward a more responsible and sustainable future." As a participant of the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively advocates sustainability and has earned widespread recognitions for its efforts. The company was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI); named to the CDP "A List" for Climate Change, Water Security, Supplier Engagement Assessment; given the highest negligible-risk rating by Sustainalytics, and recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.

Read More →

For latest updates follow us on

LinkedIn

This email has been sent to you in association with
www.biospectrumjobs.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2025 MM ACTIV. All rights reserved.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.

Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.